Head-to-head · WeighScore
Klinic vs Sesame Care
By GLP-1 ScorecardUpdated
Score comparison
Sesame Care has the higher recorded score — 87.8/100 to 60.8/100.
Sesame Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.
Before you choose
Klinic does not publish a semaglutide price, so its Klinic review sets out what it does disclose, while the Sesame Care review explains the conditions attached to Sesame Care's figure. The semaglutide cost page compares published rates across the field. Ask Klinic for a written total before treating either one as the cheaper choice.
If neither one fits, Klinic vs ShedRx and Knownwell vs Sesame Care compare each of them with another graded program, and the list of alternatives to Klinic ranks the programs closest to Klinic on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Klinic | Sesame Care |
|---|---|---|
| WeighScore | 60.8/100 | 87.8/100 |
| Grade | C | B+ |
| Site position | #341 | #2 |
| Semaglutide | Varies (branded medication; visits extra) | Brand Wegovy pill from $149/mo at 1.5/4 mg; $299 at 9/25 mg, plus required care: from $59/mo on annual subscription or $99 every 28 days (confirm billing) |
| Tirzepatide | Varies (branded medication; visits extra) | Brand Zepbound vials from $299/mo at 2.5 mg; higher doses cost more and KwikPen pages conflict, plus required care (confirm selected product and billing) |
| Coverage | Nationwide; confirm provider availability | U.S. marketplace; provider and treatment availability varies; confirm your state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #341 · C
Strengths
- Offers provider matching, insurance verification and prior-authorization support
- Wegovy, Zepbound and oral Wegovy treatment pages are published
- Zepbound program describes assistance with insurance appeals
- Publishes self-pay visit fees: from $99 initially and $75 for follow-ups
What to consider
- Medication is extra; there is no single published total covering visits and every prescription
- Insurance acceptance and benefit verification do not guarantee payment
- Terms describe monthly membership renewal and cancellation notice 14 business days before billing; confirm applicability to your plan
- Care is delivered by independent practitioners; confirm the provider and dispensing pharmacy before starting
Site position #2 · B+
Strengths
- Provider choice with advertised video visits, follow-ups and continuing messaging
- Branded injection and oral options are described, subject to prescribing, dose, insurance and pharmacy availability
- Quest lab costs are included except in nine named states; alternative lab coverage requires confirmation
- The current semaglutide page explicitly distinguishes branded products from compounded semaglutide, which it says is currently unavailable
What to consider
- The $59 care headline requires an annual subscription and excludes medication; provider-specific care rates may be higher
- Ordinary care is called monthly but also billed every 28 days; longer-term savings arithmetic needs confirmation
- Program refund wording differs from newer terms describing multi-month repricing and a 48-hour renewal notice
- Drug prices depend on dose and promotion; official KwikPen and Foundayo displays contain discrepancies
- The selected clinician, medical practice and dispensing pharmacy were not established by this review
Featured provider
Sesame Care
Sesame Care scores 87.8/100 (B+). Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.